Taysha Gene Therapies Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 05/15/2026 | 23.56 M | $105.29 M | 0.00% | 7.37% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 22.37 M | $99.99 M | 63.37% | 7.00% |
| AVORO CAPITAL ADVISORS LLC | 05/15/2026 | 21.70 M | $97.00 M | 0.00% | 6.79% |
| BLACKROCK, INC. | 05/13/2026 | 18.37 M | $82.09 M | -1.49% | 5.74% |
| VESTAL POINT CAPITAL, LP | 05/15/2026 | 18.00 M | $80.46 M | 30.91% | 5.63% |
| MORGAN STANLEY | 05/15/2026 | 17.97 M | $80.31 M | -0.63% | 5.62% |
| FMR LLC | 05/15/2026 | 14.32 M | $64.02 M | 5.86% | 4.48% |
| RTW INVESTMENTS, LP | 05/15/2026 | 13.68 M | $61.15 M | -16.58% | 4.28% |
| STATE STREET CORP | 05/15/2026 | 11.21 M | $50.10 M | 3.88% | 3.51% |
| 05/15/2026 | 10.23 M | $45.73 M | 100.00% | 3.20% | |
| OCTAGON CAPITAL ADVISORS LP | 05/15/2026 | 8.86 M | $39.60 M | 0.00% | 2.77% |
| SIREN, L.L.C. | 05/14/2026 | 8.83 M | $39.47 M | -12.83% | 2.76% |
| POLAR CAPITAL HOLDINGS PLC | 05/15/2026 | 5.65 M | $25.27 M | -28.71% | 1.77% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 5.53 M | $24.73 M | 2.69% | 1.73% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 4.43 M | $19.79 M | 10.31% | 1.38% |
| BAKER BROS. ADVISORS LP | 05/15/2026 | 4.00 M | $17.90 M | 0.00% | 1.25% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 3.28 M | $14.67 M | 3.24% | 1.03% |
| CASDIN CAPITAL, LLC | 05/15/2026 | 3.25 M | $14.53 M | 116.67% | 1.02% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/18/2026 | 2.98 M | $13.32 M | 19.38% | 0.93% |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 05/14/2026 | 2.88 M | $12.89 M | -22.53% | 0.90% |
| BARCLAYS PLC | 05/15/2026 | 2.81 M | $11.44 M | -49.23% | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 05/15/2026 | 2.72 M | $12.17 M | 0.00% | 0.85% |
| SG AMERICAS SECURITIES, LLC | 04/16/2026 | 2.18 M | $9.73 M | 178.54% | 0.68% |
| 05/08/2026 | 2.02 M | $9.04 M | 100.00% | 0.63% | |
| RICE HALL JAMES & ASSOCIATES, LLC | 05/15/2026 | 1.94 M | $8.69 M | 53.05% | 0.61% |
| NORTHERN TRUST CORP | 05/14/2026 | 1.81 M | $8.11 M | 46.55% | 0.57% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 1.81 M | $8.08 M | -4.96% | 0.57% |
| B GROUP, INC. | 05/15/2026 | 1.80 M | $8.05 M | 0.00% | 0.56% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 1.68 M | $7.50 M | 45.49% | 0.52% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 1.53 M | $6.84 M | 100.00% | 0.48% |
| PALO ALTO INVESTORS LP | 05/15/2026 | 1.39 M | $6.22 M | 17.60% | 0.44% |
| ABRDN PLC | 04/29/2026 | 1.02 M | $4.56 M | 0.00% | 0.32% |
| AFFINITY ASSET ADVISORS, LLC | 05/14/2026 | 1.00 M | $4.47 M | -69.70% | 0.31% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 05/15/2026 | 883.24 K | $3.95 M | 25.47% | 0.28% |
| QUANTUM PRIVATE WEALTH, LLC | 04/27/2026 | 849.21 K | $3.80 M | 3.60% | 0.27% |
| JPMORGAN CHASE & CO | 05/13/2026 | 754.78 K | $3.07 M | -2.53% | 0.24% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 742.08 K | $3.32 M | 111.34% | 0.23% |
| 05/15/2026 | 737.55 K | $22.22 M | -44.58% | 0.23% | |
| SANDS CAPITAL VENTURES, LLC | 05/08/2026 | 724.87 K | $3.24 M | 0.00% | 0.23% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/15/2026 | 626.36 K | $2.80 M | -11.93% | 0.20% |
| 06/04/2026 | 625.71 K | $2.80 M | 274.18% | 0.20% | |
| BANK OF NEW YORK MELLON CORP | 05/05/2026 | 608.12 K | $2.72 M | -2.60% | 0.19% |
| NUVEEN, LLC | 04/30/2026 | 549.15 K | $2.45 M | 0.71% | 0.17% |
| UBS GROUP AG | 05/05/2026 | 517.70 K | $2.31 M | 35.15% | 0.16% |
| WOODLINE PARTNERS LP | 05/15/2026 | 513.83 K | $2.30 M | 2.77% | 0.16% |
| VOYA INVESTMENT MANAGEMENT LLC | 05/12/2026 | 511.98 K | $2.29 M | 134.66% | 0.16% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 490.47 K | $2.18 M | 0.00% | 0.15% |
| JEFFERIES FINANCIAL GROUP INC. | 05/08/2026 | 479.00 K | $2.14 M | 1,816.00% | 0.15% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 461.86 K | $2.06 M | -88.06% | 0.14% |
| ACUTA CAPITAL PARTNERS, LLC | 05/15/2026 | 439.46 K | $1.96 M | -3.38% | 0.14% |
Taysha Gene Therapies Inc institutional Ownership - FAQ's
During the previous two years, 229 institutional investors and hedge funds held shares of Taysha Gene Therapies Inc. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 23.56 M
GOLDMAN SACHS GROUP INC: 22.37 M
Avoro Capital Advisors LLC: 21.7 M
BlackRock, Inc.: 18.37 M
Vestal Point Capital, LP: 18 M
MORGAN STANLEY: 17.97 M
83.08% of Taysha Gene Therapies Inc stock is owned by institutional investors.
Institutional investors have bought a total of 285.57 M shares in the last 24 months. This purchase volume represents approximately $1.31 B in transactions.